Literature DB >> 35451745

Susceptibility of Candida albicans Strains Isolated from Vaginal Secretion in Front of the Mycocins of Wickerhamomyces anomalus.

Lana Rubia B Rosseto1,2, Eloiza Cristina Martelli1,2, Jessica Cassia da Silva1,2, Bruna Larissa Nascimento1,2, Daniele S B Junges1,2, Mateus F Delabeneta1,2, Ana Paula Paris1,2, Marcos Ereno Auler3, Rafael Andrade Menolli1,2, Rita C G Simão1,2, Claudete R Paula4, Rinaldo F Gandra5,6.   

Abstract

Mycocins are substances that have the potential to affect other sensitive yeasts or microorganisms. Wickerhamomyces anomalus is a yeast that produces mycocins that have great biotechnological potential, being highly competitive in many habitats, as it is adaptable to a wide range of environmental conditions. Thus, they are targets for studies in different areas, including the environment, industry, and medical sciences. Yeasts of the genus Candida are of great importance due to the high frequency with which they colonize and infect the human host. Yeast infections are often difficult to treat due to the acquisition of resistance against antifungals, leading to studies focusing in new treatment alternatives. This work aims to verify the inhibition of Candida albicans isolated from vaginal secretion by mycocins produced by Wickerhamomyces anomalus. Tests were carried out in solid medium and microdilution tests, where mycocins proved to be efficient in inhibiting the growth of C. albicans, hemolysis, and irritation in an organotypic model, which showed that the mycocins produced by W. anomalus are safe and non-irritating. Thus, the results of this work can provide scientific evidence for the application of mycocins in the production of new antifungal alternatives.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antifungal; Killer toxins; Vulvovaginitis

Mesh:

Substances:

Year:  2022        PMID: 35451745     DOI: 10.1007/s12602-022-09940-6

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  13 in total

1.  In vitro activity of panomycocin, a novel exo-beta-1,3-glucanase isolated from Pichia anomala NCYC 434, against dermatophytes.

Authors:  Fatih Izgü; Demet Altinbay; Akif Emre Türeli
Journal:  Mycoses       Date:  2007-01       Impact factor: 4.377

2.  Susceptibility of Candida albicans Isolated from Blood to Wickerhamomyces anomalous Mycocins.

Authors:  Ana Paula Paris; Cristiane Persel; Cleber Fernando Serafin; Rita de Cássia Garcia Simão; Rinaldo Ferreira Gandra
Journal:  Curr Microbiol       Date:  2016-09-16       Impact factor: 2.188

Review 3.  Vaginitis.

Authors:  J D Sobel
Journal:  N Engl J Med       Date:  1997-12-25       Impact factor: 91.245

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Antibiotic Activity of Wickerhamomyces anomalus Mycocins on Multidrug-Resistant Acinetobacter baumannii.

Authors:  Daniele S B Junges; Mateus F Delabeneta; Lana Rubia B Rosseto; Bruna L Nascimento; Ana Paula Paris; Cristiane Persel; Eduardo A Loth; Rita C G Simão; Rafael A Menolli; Claudete R Paula; Rinaldo F Gandra
Journal:  Microb Ecol       Date:  2020-02-15       Impact factor: 4.552

6.  Genome sequence of Wickerhamomyces anomalus DSM 6766 reveals genetic basis of biotechnologically important antimicrobial activities.

Authors:  Jessica Schneider; Oliver Rupp; Eva Trost; Sebastian Jaenicke; Volkmar Passoth; Alexander Goesmann; Andreas Tauch; Karina Brinkrolf
Journal:  FEMS Yeast Res       Date:  2012-02-23       Impact factor: 2.796

Review 7.  The viral killer system in yeast: from molecular biology to application.

Authors:  Manfred J Schmitt; Frank Breinig
Journal:  FEMS Microbiol Rev       Date:  2002-08       Impact factor: 16.408

8.  Use of molecular methods in identification of Candida species and evaluation of fluconazole resistance.

Authors:  Meltem Yalinay Cirak; Ayse Kalkanci; Semra Kustimur
Journal:  Mem Inst Oswaldo Cruz       Date:  2004-03-09       Impact factor: 2.743

9.  Treatment of FANCA cells with resveratrol and N-acetylcysteine: a comparative study.

Authors:  Marta Columbaro; Silvia Ravera; Cristina Capanni; Isabella Panfoli; Paola Cuccarolo; Giorgia Stroppiana; Paolo Degan; Enrico Cappelli
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

Review 10.  Bioprotective Role of Yeasts.

Authors:  Serena Muccilli; Cristina Restuccia
Journal:  Microorganisms       Date:  2015-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.